Back to search

United Kingdom· GB-APID-3929911000001104

Orelox 100mg tablets

A cefpodoxime product containing cefpodoxime, registered in United Kingdom by Sanofi. The same ATC class is registered in 6 of our 19 countries.

ATC J01DD13

Checked against NHS dm+d (United Kingdom) on

Informational only — not a medical device.

SOURCE REGISTER · GBNHS dm+d (United Kingdom)normalisedOrelox 100mg tabletsATCJ01DD13REGISTER NO.GB-APID-3929911000001…PACKS LISTED1CHECKEDSeptember 13, 2026

Where it is registered

Cefpodoxime is registered in 6 of 19 countries.

Countries holding a registration under ATC J01DD13 (cefpodoxime), each read from that country’s own register.

  • This record: United Kingdom, from NHS dm+d (United Kingdom)
  • 4 of them publish a price we can compare per daily dose

Cefpodoxime · ATC J01DD13

6 / 19 countries

  • Czechiaprice
  • Finlandprice
  • Germany
  • Italyprice
  • Switzerlandprice
  • United Kingdom
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of cefpodoxime costs, country by country.

Normalised to the WHO defined daily dose (0.4 g), the median price runs from $3.33 in Italy to $8.39 in Switzerland — a ×2.5 gap.

  • 2 markets with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown

Cefpodoxime · price per daily dose (0.4 g)

USD · FX 28 Sept 2026

  • CH Switzerland$8.39
  • IT Italy$3.33
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

NHS dm+d (United Kingdom)
Active substance
Cefpodoxime
Manufacturer
Sanofi
Country
United Kingdom (GB)
ATC code
J01DD13
ATC class
Cefpodoxime
Defined daily dose
0.4 g, O
Reimbursed
Not published by this register
Source register
NHS dm+d (United Kingdom)
Last checked
September 13, 2026

Packs & prices · 1

  • gtin
    5013841103354

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

113 interactions on record for cefpodoxime.

Graded by severity as the source publishes them — 45 moderate. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Cefpodoxime · interactions on record

113 records

  • 45 moderate
  • 68 info

Most severe, free to view

  • Magnesium carbonateA02AA01moderate
  • Magnesium oxideA02AA02moderate
  • Magnesium hydroxideA02AA04moderate
  • Kombinationen von AluminiumsalzenA02AB10moderate
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Cefpodoxime in 5 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All cefpodoxime products

Authorised across Europe · EMA

The same active substance is authorised in 10 EEA countries. Names it is sold under:

  • Austria · Biocef
  • Bulgaria · Ximebac, Фоксеро
  • Czechia · Forexo
  • Germany · Cefpodoxim 1 A Pharma, Cefpodoxim Al
  • France · Cefpodoxime Biogaran, Cefpodoxime Cristers Pharma
  • Croatia · Rexocef
  • Italy · Cefpodoxima Mylan, Cefpodoxima Sandoz
  • Portugal · Cefpodoxima Alkaloid
  • Romania · Forexo
  • Slovenia · Trexodo

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/f265b32f-b3e1-42af-9ce1-c90cd59ce9be
GET /v1/drugs/f265b32f-b3e1-42af-9ce1-c90cd59ce9be?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "apid": "3929911000001104",
  "desc": "Orelox 100mg tablets (Sanofi)",
  "form": "Oral tablet",
  "vpid": "41944011000001106",
  "source": "dmd",
  "vtm_id": "775109003",
  "strength": "100 mg",
  "substance": "Cefpodoxime",
  "ingredient": "Cefpodoxime proxetil",
  "supplier_code": "9190711000001101"
}

See everything about cefpodoxime.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.